Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 25630 entries
Sorted by: Best Match Show Resources per page
Canine parvovirus: current perspective.

Indian journal of virology : an official organ of Indian Virological Society

Nandi S, Kumar M.
PMID: 23637476
Indian J Virol. 2010 Jun;21(1):31-44. doi: 10.1007/s13337-010-0007-y. Epub 2010 Sep 03.

Canine parvovirus 2 (CPV-2) has been considered to be an important pathogen of domestic and wild canids and has spread worldwide since its emergence in 1978. It has been reported from Asia, Australia, New Zealand, the Americas and Europe....

Cite
Nandi S, Kumar M. Canine parvovirus: current perspective. Indian J Virol. 2010;21(1):31-44doi: 10.1007/s13337-010-0007-y.
Nandi, S., & Kumar, M. (2010). Canine parvovirus: current perspective. Indian journal of virology : an official organ of Indian Virological Society, 21(1), 31-44. https://doi.org/10.1007/s13337-010-0007-y
Nandi, S, and Kumar, Manoj. "Canine parvovirus: current perspective." Indian journal of virology : an official organ of Indian Virological Society vol. 21,1 (2010): 31-44. doi: https://doi.org/10.1007/s13337-010-0007-y
Nandi S, Kumar M. Canine parvovirus: current perspective. Indian J Virol. 2010 Jun;21(1):31-44. doi: 10.1007/s13337-010-0007-y. Epub 2010 Sep 03. PMID: 23637476; PMCID: PMC3550768.
Copy Download .nbib Format: NLM
Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies.

Indian journal of virology : an official organ of Indian Virological Society

Mukherjee A, Chawla-Sarkar M.
PMID: 23637497
Indian J Virol. 2011 Jun;22(1):11-23. doi: 10.1007/s13337-011-0039-y. Epub 2011 Jun 14.

For centuries, acute diarrhea has been a major cause of death in young children worldwide, and until 1973, before rotavirus was discovered; no infectious agents could be identified in about 80% of patients admitted to hospital with severe dehydrating...

Cite
Mukherjee A, Chawla-Sarkar M. Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies. Indian J Virol. 2011;22(1):11-23doi: 10.1007/s13337-011-0039-y.
Mukherjee, A., & Chawla-Sarkar, M. (2011). Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies. Indian journal of virology : an official organ of Indian Virological Society, 22(1), 11-23. https://doi.org/10.1007/s13337-011-0039-y
Mukherjee, Anupam, and Chawla-Sarkar, Mamta. "Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies." Indian journal of virology : an official organ of Indian Virological Society vol. 22,1 (2011): 11-23. doi: https://doi.org/10.1007/s13337-011-0039-y
Mukherjee A, Chawla-Sarkar M. Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies. Indian J Virol. 2011 Jun;22(1):11-23. doi: 10.1007/s13337-011-0039-y. Epub 2011 Jun 14. PMID: 23637497; PMCID: PMC3550723.
Copy Download .nbib Format: NLM
Self Replicating Gene Vaccine Carrying P1-2A Gene of FMDV Serotype O and its Effects on the Immune Responses of Cattle.

Indian journal of virology : an official organ of Indian Virological Society

Nagarajan G, Ravikumar P, Ashok Kumar C, Reddy GR, Dechamma HJ, Suryanarayana VV.
PMID: 23637502
Indian J Virol. 2011 Jun;22(1):50-8. doi: 10.1007/s13337-011-0032-5. Epub 2011 May 10.

DNA vaccines are considered as alternatives to live attenuated ones for those diseases like foot-and-mouth disease (FMD) where the production and application of live vaccines have been found unsuccessful. However, stability of DNA and the quantity of antigen expressed...

Cite
Nagarajan G, Ravikumar P, Ashok Kumar C, et al. Self Replicating Gene Vaccine Carrying P1-2A Gene of FMDV Serotype O and its Effects on the Immune Responses of Cattle. Indian J Virol. 2011;22(1):50-8doi: 10.1007/s13337-011-0032-5.
Nagarajan, G., Ravikumar, P., Ashok Kumar, C., Reddy, G. R., Dechamma, H. J., & Suryanarayana, V. V. (2011). Self Replicating Gene Vaccine Carrying P1-2A Gene of FMDV Serotype O and its Effects on the Immune Responses of Cattle. Indian journal of virology : an official organ of Indian Virological Society, 22(1), 50-8. https://doi.org/10.1007/s13337-011-0032-5
Nagarajan, G, et al. "Self Replicating Gene Vaccine Carrying P1-2A Gene of FMDV Serotype O and its Effects on the Immune Responses of Cattle." Indian journal of virology : an official organ of Indian Virological Society vol. 22,1 (2011): 50-8. doi: https://doi.org/10.1007/s13337-011-0032-5
Nagarajan G, Ravikumar P, Ashok Kumar C, Reddy GR, Dechamma HJ, Suryanarayana VV. Self Replicating Gene Vaccine Carrying P1-2A Gene of FMDV Serotype O and its Effects on the Immune Responses of Cattle. Indian J Virol. 2011 Jun;22(1):50-8. doi: 10.1007/s13337-011-0032-5. Epub 2011 May 10. PMID: 23637502; PMCID: PMC3550724.
Copy Download .nbib Format: NLM
Analysis of public responses to preparedness policies: the cases of H1N1 influenza vaccination and gas mask distribution.

Israel journal of health policy research

Velan B, Boyko V, Shenhar G, Lerner-Geva L, Kaplan G.
PMID: 23537171
Isr J Health Policy Res. 2013 Mar 27;2(1):11. doi: 10.1186/2045-4015-2-11.

BACKGROUND: During several months in 2009-2010, the Israeli population was asked to take part in two preparedness programs: Acquisition of gas masks against a potential chemical-warfare attack, and vaccination against the A/H1N1 influenza pandemics. Compliance with the first request...

Cite
Velan B, Boyko V, Shenhar G, et al. Analysis of public responses to preparedness policies: the cases of H1N1 influenza vaccination and gas mask distribution. Isr J Health Policy Res. 2013;2(1):11doi: 10.1186/2045-4015-2-11.
Velan, B., Boyko, V., Shenhar, G., Lerner-Geva, L., & Kaplan, G. (2013). Analysis of public responses to preparedness policies: the cases of H1N1 influenza vaccination and gas mask distribution. Israel journal of health policy research, 2(1), 11. https://doi.org/10.1186/2045-4015-2-11
Velan, Baruch, et al. "Analysis of public responses to preparedness policies: the cases of H1N1 influenza vaccination and gas mask distribution." Israel journal of health policy research vol. 2,1 (2013): 11. doi: https://doi.org/10.1186/2045-4015-2-11
Velan B, Boyko V, Shenhar G, Lerner-Geva L, Kaplan G. Analysis of public responses to preparedness policies: the cases of H1N1 influenza vaccination and gas mask distribution. Isr J Health Policy Res. 2013 Mar 27;2(1):11. doi: 10.1186/2045-4015-2-11. PMID: 23537171; PMCID: PMC3621681.
Copy Download .nbib Format: NLM
Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors.

Journal of ovarian research

Bradaric MJ, Barua A, Penumatsa K, Yi Y, Edassery SL, Sharma S, Abramowicz JS, Bahr JM, Luborsky JL.
PMID: 21356044
J Ovarian Res. 2011 Feb 28;4(1):4. doi: 10.1186/1757-2215-4-4.

BACKGROUND: Sphingosine-1 receptor 1 (S1P1) plays a major role in regulating lymphocyte egress from peripheral lymph tissue. Lymphocyte trafficking is potentially a critical response to tumors and to tumor vaccines. Also, the receptor has been shown to influence metastasis....

Cite
Bradaric MJ, Barua A, Penumatsa K, et al. Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors. J Ovarian Res. 2011;4(1):4doi: 10.1186/1757-2215-4-4.
Bradaric, M. J., Barua, A., Penumatsa, K., Yi, Y., Edassery, S. L., Sharma, S., Abramowicz, J. S., Bahr, J. M., & Luborsky, J. L. (2011). Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors. Journal of ovarian research, 4(1), 4. https://doi.org/10.1186/1757-2215-4-4
Bradaric, Michael J, et al. "Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors." Journal of ovarian research vol. 4,1 (2011): 4. doi: https://doi.org/10.1186/1757-2215-4-4
Bradaric MJ, Barua A, Penumatsa K, Yi Y, Edassery SL, Sharma S, Abramowicz JS, Bahr JM, Luborsky JL. Sphingosine-1 phosphate receptor (S1p1), a critical receptor controlling human lymphocyte trafficking, is expressed in hen and human ovaries and ovarian tumors. J Ovarian Res. 2011 Feb 28;4(1):4. doi: 10.1186/1757-2215-4-4. PMID: 21356044; PMCID: PMC3058111.
Copy Download .nbib Format: NLM
Usefulness of influenza vaccination during pregnancy to mothers and young infants.

Expert review of vaccines

Hisano M, Yamaguchi K.
PMID: 23002970
Expert Rev Vaccines. 2012 Aug;11(8):903-5. doi: 10.1586/erv.12.67.

As pregnant women are at increased risk of influenza infection and influenza-related complications, immunization with inactivated influenza vaccine during the influenza season is recommended. Vaccination during pregnancy is considered to provide benefits for both the mothers and their young...

Cite
Hisano M, Yamaguchi K. Usefulness of influenza vaccination during pregnancy to mothers and young infants. Expert Rev Vaccines. 2012;11(8):903-5doi: 10.1586/erv.12.67.
Hisano, M., & Yamaguchi, K. (2012). Usefulness of influenza vaccination during pregnancy to mothers and young infants. Expert review of vaccines, 11(8), 903-5. https://doi.org/10.1586/erv.12.67
Hisano, Michi, and Yamaguchi, Koushi. "Usefulness of influenza vaccination during pregnancy to mothers and young infants." Expert review of vaccines vol. 11,8 (2012): 903-5. doi: https://doi.org/10.1586/erv.12.67
Hisano M, Yamaguchi K. Usefulness of influenza vaccination during pregnancy to mothers and young infants. Expert Rev Vaccines. 2012 Aug;11(8):903-5. doi: 10.1586/erv.12.67. PMID: 23002970.
Copy Download .nbib Format: NLM
B-cell or T-cell immunity?.

Immunology today

McMichael AJ, Askonas BA, Webster RG, Laver WG.
PMID: 25290224
Immunol Today. 1982 Oct;3(10):255-60. doi: 10.1016/0167-5699(82)90077-9.

The influenza virus behaves unpredictably and can cause devastating pandemics. Nearly 50 years after its first isolation it is probably the most infectious agent known that we cannot yet control. Why? The answer lies in the virus's unique capacity...

Cite
McMichael AJ, Askonas BA, Webster RG, et al. B-cell or T-cell immunity?. Immunol Today. 1982;3(10):255-60doi: 10.1016/0167-5699(82)90077-9.
McMichael, A. J., Askonas, B. A., Webster, R. G., & Laver, W. G. (1982). B-cell or T-cell immunity?. Immunology today, 3(10), 255-60. https://doi.org/10.1016/0167-5699(82)90077-9
McMichael, A J, et al. "B-cell or T-cell immunity?." Immunology today vol. 3,10 (1982): 255-60. doi: https://doi.org/10.1016/0167-5699(82)90077-9
McMichael AJ, Askonas BA, Webster RG, Laver WG. B-cell or T-cell immunity?. Immunol Today. 1982 Oct;3(10):255-60. doi: 10.1016/0167-5699(82)90077-9. PMID: 25290224.
Copy Download .nbib Format: NLM
Evaluation of procedures for typing of group B .

PeerJ

Slotved HC, Hoffmann S.
PMID: 28321367
PeerJ. 2017 Mar 16;5:e3105. doi: 10.7717/peerj.3105. eCollection 2017.

BACKGROUND: This study evaluates two procedures for typing of METHODS: A total of 616 clinical GBS isolates from 2010 to 2014 were tested with both a latex test and the LP test. Among these, 66 isolates were genotyped by...

Cite
Slotved HC, Hoffmann S. Evaluation of procedures for typing of group B . PeerJ. 2017;5:e3105doi: 10.7717/peerj.3105.
Slotved, H. C., & Hoffmann, S. (2017). Evaluation of procedures for typing of group B . PeerJ, 5e3105. https://doi.org/10.7717/peerj.3105
Slotved, Hans-Christian, and Hoffmann, Steen. "Evaluation of procedures for typing of group B ." PeerJ vol. 5 (2017): e3105. doi: https://doi.org/10.7717/peerj.3105
Slotved HC, Hoffmann S. Evaluation of procedures for typing of group B . PeerJ. 2017 Mar 16;5:e3105. doi: 10.7717/peerj.3105. eCollection 2017. PMID: 28321367; PMCID: PMC5357338.
Copy Download .nbib Format: NLM
Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin.

Frontiers in immunology

Peng B, Peng N, Zhang Y, Zhang F, Li X, Chang H, Fang F, Wang F, Lu F, Chen Z.
PMID: 28912784
Front Immunol. 2017 Aug 31;8:1070. doi: 10.3389/fimmu.2017.01070. eCollection 2017.

The 2009 H1N1 influenza (Pdm09) pandemic has been referred to as the first influenza pandemic of the twenty-first century. There is a marked difference in antigenicity between the pandemic H1N1 virus and past seasonal H1N1 viruses, which allowed the...

Cite
Peng B, Peng N, Zhang Y, et al. Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin. Front Immunol. 2017;8:1070doi: 10.3389/fimmu.2017.01070.
Peng, B., Peng, N., Zhang, Y., Zhang, F., Li, X., Chang, H., Fang, F., Wang, F., Lu, F., & Chen, Z. (2017). Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin. Frontiers in immunology, 81070. https://doi.org/10.3389/fimmu.2017.01070
Peng, Bo, et al. "Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin." Frontiers in immunology vol. 8 (2017): 1070. doi: https://doi.org/10.3389/fimmu.2017.01070
Peng B, Peng N, Zhang Y, Zhang F, Li X, Chang H, Fang F, Wang F, Lu F, Chen Z. Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin. Front Immunol. 2017 Aug 31;8:1070. doi: 10.3389/fimmu.2017.01070. eCollection 2017. PMID: 28912784; PMCID: PMC5583165.
Copy Download .nbib Format: NLM
Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin.

Cost effectiveness and resource allocation : C/E

Kaucley L, Levy P.
PMID: 26300696
Cost Eff Resour Alloc. 2015 Aug 20;13:14. doi: 10.1186/s12962-015-0039-7. eCollection 2015.

BACKGROUND: This study was carried out at district level to describe the cost structure and measure the effectiveness of delivering supplementary immunization activity (SIA) and routine immunization (RI) for measles in Benin, a country heavily affected by this disease.METHODS:...

Cite
Kaucley L, Levy P. Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin. Cost Eff Resour Alloc. 2015;13:14doi: 10.1186/s12962-015-0039-7.
Kaucley, L., & Levy, P. (2015). Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin. Cost effectiveness and resource allocation : C/E, 1314. https://doi.org/10.1186/s12962-015-0039-7
Kaucley, Landry, and Levy, Pierre. "Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin." Cost effectiveness and resource allocation : C/E vol. 13 (2015): 14. doi: https://doi.org/10.1186/s12962-015-0039-7
Kaucley L, Levy P. Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin. Cost Eff Resour Alloc. 2015 Aug 20;13:14. doi: 10.1186/s12962-015-0039-7. eCollection 2015. PMID: 26300696; PMCID: PMC4545866.
Copy Download .nbib Format: NLM
Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis.

Frontiers in microbiology

Somani VK, Aggarwal S, Singh D, Prasad T, Bhatnagar R.
PMID: 26925042
Front Microbiol. 2016 Feb 17;7:169. doi: 10.3389/fmicb.2016.00169. eCollection 2016.

Lipid rafts are dynamic, nanoscale assemblies of specific proteins and lipids, distributed heterogeneously on eukaryotic membrane. Flotillin-1, a conserved eukaryotic raft marker protein (RMP) harbor SPFH (Stomatin, Prohibitin, Flotillin, and HflK/C) and oligomerization domains to regulate various cellular processes...

Cite
Somani VK, Aggarwal S, Singh D, et al. Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis. Front Microbiol. 2016;7:169doi: 10.3389/fmicb.2016.00169.
Somani, V. K., Aggarwal, S., Singh, D., Prasad, T., & Bhatnagar, R. (2016). Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis. Frontiers in microbiology, 7169. https://doi.org/10.3389/fmicb.2016.00169
Somani, Vikas K, et al. "Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis." Frontiers in microbiology vol. 7 (2016): 169. doi: https://doi.org/10.3389/fmicb.2016.00169
Somani VK, Aggarwal S, Singh D, Prasad T, Bhatnagar R. Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis. Front Microbiol. 2016 Feb 17;7:169. doi: 10.3389/fmicb.2016.00169. eCollection 2016. PMID: 26925042; PMCID: PMC4756111.
Copy Download .nbib Format: NLM
Pharmacists' Attitudes and Perceived Barriers to Human Papillomavirus (HPV) Vaccination Services.

Pharmacy (Basel, Switzerland)

Hastings TJ, Hohmann LA, McFarland SJ, Teeter BS, Westrick SC.
PMID: 28970457
Pharmacy (Basel). 2017 Aug 07;5(3). doi: 10.3390/pharmacy5030045.

Use of non-traditional settings such as community pharmacies has been suggested to increase human papillomavirus (HPV) vaccination uptake and completion rates. The objectives of this study were to explore HPV vaccination services and strategies employed by pharmacies to increase...

Cite
Hastings TJ, Hohmann LA, McFarland SJ, et al. Pharmacists' Attitudes and Perceived Barriers to Human Papillomavirus (HPV) Vaccination Services. Pharmacy (Basel). 2017;5(3)doi: 10.3390/pharmacy5030045.
Hastings, T. J., Hohmann, L. A., McFarland, S. J., Teeter, B. S., & Westrick, S. C. (2017). Pharmacists' Attitudes and Perceived Barriers to Human Papillomavirus (HPV) Vaccination Services. Pharmacy (Basel, Switzerland), 5(3), . https://doi.org/10.3390/pharmacy5030045
Hastings, Tessa J, et al. "Pharmacists' Attitudes and Perceived Barriers to Human Papillomavirus (HPV) Vaccination Services." Pharmacy (Basel, Switzerland) vol. 5,3 (2017). doi: https://doi.org/10.3390/pharmacy5030045
Hastings TJ, Hohmann LA, McFarland SJ, Teeter BS, Westrick SC. Pharmacists' Attitudes and Perceived Barriers to Human Papillomavirus (HPV) Vaccination Services. Pharmacy (Basel). 2017 Aug 07;5(3). doi: 10.3390/pharmacy5030045. PMID: 28970457; PMCID: PMC5622357.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 25630 entries